A detailed history of Prelude Capital Management, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Prelude Capital Management, LLC holds 4,130 shares of XBI stock, worth $413,000. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,130
Previous 4,130 -0.0%
Holding current value
$413,000
Previous $408,000 -0.0%
% of portfolio
0.03%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$90.87 - $102.43 $375,293 - $423,035
4,130 New
4,130 $408,000
Q4 2023

Feb 14, 2024

BUY
$64.12 - $90.86 $18,851 - $26,712
294 Added 9.35%
3,440 $307,000
Q3 2023

Nov 14, 2023

BUY
$71.88 - $85.76 $226,134 - $269,800
3,146 New
3,146 $229,000
Q3 2021

Nov 15, 2021

SELL
$118.69 - $138.49 $1.16 Million - $1.36 Million
-9,797 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$122.48 - $139.69 $1.2 Million - $1.37 Million
9,797 New
9,797 $1.33 Million

Others Institutions Holding XBI

About SPDR SER TR SPDR S&P BIOTECH E


  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.